Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera - PubMed (original) (raw)
. 1998 Feb 26;338(9):572-80.
doi: 10.1056/NEJM199802263380903.
Affiliations
- PMID: 9475764
- DOI: 10.1056/NEJM199802263380903
Free article
Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera
A R Moliterno et al. N Engl J Med. 1998.
Free article
Abstract
Background: The cause of polycythemia vera, which originates from a multipotent hematopoietic progenitor cell, is unknown. Thrombopoietin is a hematopoietic growth factor that regulates the production of multipotent hematopoietic progenitor cells and platelets. To evaluate the possibility that an abnormality in thrombopoietin-mediated signal transduction might be involved in the pathogenesis of polycythemia vera, we examined thrombopoietin-induced tyrosine phosphorylation of proteins and the expression of the thrombopoietin receptor in platelets from patients with the disease.
Methods: Platelets were isolated from the blood of patients with polycythemia vera or other chronic myeloproliferative disorders and control subjects. The platelets were exposed to either thrombopoietin or thrombin and then lysed for analysis of tyrosine phosphorylation of platelet proteins and the expression of the proteins by means of immunoblotting. Expression of the thrombopoietin receptor (Mpl) by platelets and megakaryocytes was also assessed.
Results: Thrombopoietin-mediated tyrosine phosphorylation of proteins was impaired in platelets from 20 patients with polycythemia vera and 3 with idiopathic myelofibrosis, but not in 4 patients with essential thrombocytosis, 3 with chronic myelogenous leukemia, 6 with secondary erythrocytosis, 2 with iron-deficiency anemia, 4 with hemochromatosis, or 5 normal subjects. Thrombin-mediated tyrosine phosphorylation of proteins was intact in platelets from patients with polycythemia vera, and the tyrosine kinases and substrates involved in the process were present in normal amounts. However, expression of the platelet thrombopoietin receptor MpI was markedly reduced or absent in 34 of 34 patients with polycythemia vera and in 13 of 14 patients with idiopathic myelofibrosis. Impaired thrombopoietin-induced tyrosine phosphorylation of proteins in patients with these two diseases was uniformly associated with markedly reduced expression of MpI or the lack of its expression. In patients with polycythemia vera, reduced expression of MpI by platelets was associated with reduced expression of MpI by megakaryocytes.
Conclusions: Reduced expression of the thrombopoietin receptor MpI is characteristic of polycythemia vera and idiopathic myelofibrosis. The abnormality appears to distinguish polycythemia vera from other-forms of erythrocytosis.
Comment in
- Polycythemia vera--chance, death, and mutability.
Schwartz RS. Schwartz RS. N Engl J Med. 1998 Feb 26;338(9):613-5. doi: 10.1056/NEJM199802263380910. N Engl J Med. 1998. PMID: 9475771 No abstract available. - Signal transduction in platelets from patients with polycythemia vera.
Lange W, Martens UM, Waller CF. Lange W, et al. N Engl J Med. 1998 Jul 9;339(2):127-8. N Engl J Med. 1998. PMID: 9669902 No abstract available.
Similar articles
- A novel thrombopoietin signaling defect in polycythemia vera platelets.
Moliterno AR, Siebel KE, Sun AY, Hankins WD, Spivak JL. Moliterno AR, et al. Stem Cells. 1998;16 Suppl 2:185-92. doi: 10.1002/stem.5530160721. Stem Cells. 1998. PMID: 11012190 - Signal transduction in platelets from patients with polycythemia vera.
Lange W, Martens UM, Waller CF. Lange W, et al. N Engl J Med. 1998 Jul 9;339(2):127-8. N Engl J Med. 1998. PMID: 9669902 No abstract available. - Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
Bock O, Schlué J, Mengel M, Büsche G, Serinsöz E, Kreipe H. Bock O, et al. J Pathol. 2004 May;203(1):609-15. doi: 10.1002/path.1558. J Pathol. 2004. PMID: 15095485 - Etiology of the myeloproliferative disorders: the role of thrombopoietin.
Kaushansky K. Kaushansky K. Semin Hematol. 2003 Jan;40(1 Suppl 1):6-9. doi: 10.1053/shem.2003.50027. Semin Hematol. 2003. PMID: 12682875 Review. - [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
Germeshausen M, Schulze H, Gaudig A, Krukemeier S, Strauss G, Welte K, Ballmaier M. Germeshausen M, et al. Klin Padiatr. 2001 Jul-Aug;213(4):155-61. doi: 10.1055/s-2001-16846. Klin Padiatr. 2001. PMID: 11528548 Review. German.
Cited by
- Lysosomal degradation targets mutant calreticulin and the thrombopoietin receptor in myeloproliferative neoplasms.
Kaur A, Venkatesan A, Kandarpa M, Talpaz M, Raghavan M. Kaur A, et al. Blood Adv. 2024 Jul 9;8(13):3372-3387. doi: 10.1182/bloodadvances.2023011432. Blood Adv. 2024. PMID: 38640435 Free PMC article. - Philadelphia-Negative MPN: A Molecular Journey, from Hematopoietic Stem Cell to Clinical Features.
Giai V, Secreto C, Freilone R, Pregno P. Giai V, et al. Medicina (Kaunas). 2021 Sep 30;57(10):1043. doi: 10.3390/medicina57101043. Medicina (Kaunas). 2021. PMID: 34684081 Free PMC article. Review. - Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.
Huang YC, Wang CY. Huang YC, et al. Int J Mol Sci. 2021 Sep 13;22(18):9867. doi: 10.3390/ijms22189867. Int J Mol Sci. 2021. PMID: 34576030 Free PMC article. Review. - In and out: Traffic and dynamics of thrombopoietin receptor.
Roy A, Shrivastva S, Naseer S. Roy A, et al. J Cell Mol Med. 2021 Oct;25(19):9073-9083. doi: 10.1111/jcmm.16878. Epub 2021 Aug 27. J Cell Mol Med. 2021. PMID: 34448528 Free PMC article. Review. - MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutations.
Yasuda S, Aoyama S, Yoshimoto R, Li H, Watanabe D, Akiyama H, Yamamoto K, Fujiwara T, Najima Y, Doki N, Sakaida E, Edahiro Y, Imai M, Araki M, Komatsu N, Miura O, Kawamata N. Yasuda S, et al. Int J Hematol. 2021 Oct;114(4):424-440. doi: 10.1007/s12185-021-03180-0. Epub 2021 Jun 24. Int J Hematol. 2021. PMID: 34165774
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources